Submit a notification by the deadline to keep active substances in the GB Review Programme HSE has published an open invitation (.pdf) to provide an opportunity for a person, company or task force/consortium to notify an intention to take up or take over the role of participant in the GB Review Programme for the following active substance/product type combination. Anyone wishing to support the active substance/product type combination listed below in GB will need to submit a notification to HSE by the following deadline:
- Peanut butter (CAS n/a EC n/a) in product type 19
14 March 2024
If a notification to take over the role of participant is not received, this active substance/product type combination will be subject to a GB non-approval decision. Biocidal products containing active substances with GB non-approval decisions for the relevant product types will have to be removed from the GB market. HSE will provide separate updates on these where relevant. If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of the active substance/product type combination listed above, please contact us. Take action to keep your active substance in the GB Review Programme The active substance/product type combinations listed below have been successfully notified into the GB Review Programme following open invitations. The next step is for a full active substance dossier to be submitted to HSE by the following deadlines:
- (Benzylyoxy)methanol (CAS 14548-60-8 EC 238-588-8) in product type 6
21 March 2025
- Monolinuron (CAS 1746-81-2 EC 217-129-5) in product type 2
23 March 2025
Only the person, company or task force/consortium that successfully notified the active substance/product type combinations listed above can submit a dossier. If any of these active substance/product type combinations are important to you, consider contacting the notifier to let them know. You may even be able to join them in supporting the active substance.Check the list of successful notifiers. If a dossier is not submitted by the deadline, these active substance/product type combinations will be subject to a GB non-approval decision. Biocidal products containing active substances with GB non-approval decisions for the relevant product types will have to be removed from the GB market. HSE will provide separate updates on these where relevant. |